James Healy, Director at BioAge Labs, Inc. (BIOA), bought 2,304,901 shares at $18.00 ($12.0M) on 2024-09-27, disclosed to the SEC on 2024-09-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,638,236 | $0 | 0.0% |
| 2 | $18.00 | 11,113 | $200K | 1.7% |
| 3 | $18.00 | 18,353 | $330K | 2.8% |
| 4 | $18.00 | 21,814 | $393K | 3.3% |
| 5 | $18.00 | 26,497 | $477K | 4.0% |
| 6 | $18.00 | 588,888 |
| $10.6M |
| 88.3% |
| Total | $5.21 avg | 2,304,901 | $12.0M | 100% |
| Filing → |
| AVBP | BUY | 2024-01-31 | $8.0M | — | Filing → |
| NTRA | SELL | 2023-12-22 | $37.8M | — | Filing → |
| CINC | SELL | 2023-02-27 | $86K | — | Filing → |